Viewing Study NCT04705350


Ignite Creation Date: 2025-12-24 @ 5:25 PM
Ignite Modification Date: 2026-01-02 @ 5:05 AM
Study NCT ID: NCT04705350
Status: COMPLETED
Last Update Posted: 2022-07-19
First Post: 2021-01-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Test Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Intravenous Doses of Zampilimab in Healthy Participants
Sponsor: UCB Biopharma SRL
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module